dermatology

List of likely buyers of Novartis’ Dermatology division ($2bn) takes shape
List of likely buyers of Novartis’ Dermatology division ($2bn) takes shape
GoinPharma
Novartis
dermatology
generics
M&A
Aurobindo
Shanghai Fosun Pharmaceutical
Apollo Global Management
Flag link:
Aurobindo bids $1.6B for Novartis' U.S. dermatology generics: report
Aurobindo bids $1.6B for Novartis' U.S. dermatology generics: report
Fierce Pharma
Aurobindo
Novartis
Sandoz
M&A
dermatology
India
Flag link:
Seasoned reps could help Aclaris' Eskata with a pleasantly surprising launch: analyst
Seasoned reps could help Aclaris' Eskata with a pleasantly surprising launch: analyst
Fierce Pharma
drug reps
dermatology
Aclaris
Eskata
drug launches
seborrheic keratoses
Flag link:
Novartis Weighs Sale of Dermatology Generics Business
Novartis Weighs Sale of Dermatology Generics Business
Bloomberg
Novartis
dermatology
M&A
Flag link:
Nestle plans to ax hundreds of R&D staffers, shutter big dermatology campus
Nestle plans to ax hundreds of R&D staffers, shutter big dermatology campus
Endpoints
R&D
layoffs
Galderma
Nestle
dermatology
Flag link:
5 Reasons Valeant's Situation Could Get Worse
5 Reasons Valeant's Situation Could Get Worse
Motley Fool
Valeant Pharmaceuticals
LOEs
dermatology
debt
Flag link:
Novartis bags a new eczema drug, builds dermatology pipeline with Ziarco buyout
Novartis bags a new eczema drug, builds dermatology pipeline with Ziarco buyout
Endpoints
Novartis
eczema
dermatology
M&A
ZPL389
Ziarco
Flag link:
Mylan, Lupin, others now in the mix for $1.1B Bayer derm buy
Mylan, Lupin, others now in the mix for $1.1B Bayer derm buy
Fierce Pharma
Mylan Labs
Lupin
Bayer
dermatology
M&A
Cadila
Torrent Pharmaceuticals
Flag link:
Teva, Perrigo and Sun join list of suitors checking out Bayer's $1.1B derm unit
Teva, Perrigo and Sun join list of suitors checking out Bayer's $1.1B derm unit
Fierce Pharma
Teva Pharmaceutical
Perrigo
Sun Pharma
Bayer
dermatology
M&A
Flag link:
Bayer eyes $1B-plus dermatology sale to fund Monsanto quest
Bayer eyes $1B-plus dermatology sale to fund Monsanto quest
Fierce Pharma
Bayer
dermatology
Monsanto
M&A
Flag link:
Valeant Pharmaceuticals Intl Inc (VRX) May Have A Buyer For Derma Assets; Finally Some Good News?
Valeant Pharmaceuticals Intl Inc (VRX) May Have A Buyer For Derma Assets; Finally Some Good News?
Bidness, ETC
Valeant Pharmaceuticals
dermatology
M&A
Almirall
Spain
Flag link:
AstraZeneca sells off dermatology drug rights to LEO Pharma
AstraZeneca sells off dermatology drug rights to LEO Pharma
BioPharma Dive
AstraZeneca
dermatology
LEO Pharma
M&A
Flag link:
Valeant Pharmaceuticals Intl Inc (VRX) Stock Drops on Sale of Dermatology Assets
Valeant Pharmaceuticals Intl Inc (VRX) Stock Drops on Sale of Dermatology Assets
Bidness, ETC
Valeant Pharmaceuticals
dermatology
M&A
Solta
Obagi Medical Products
Flag link:
Valeant Pharmaceuticals' 2016 Outlook Blemished by Continued Dermatology Woes
Valeant Pharmaceuticals' 2016 Outlook Blemished by Continued Dermatology Woes
Motley Fool
Valeant Pharmaceuticals
dermatology
opthalmology
Flag link:
Mylan NV Expands Dermatology Business with $1 Billion Renaissance Acquisition: A Smart Move?
Mylan NV Expands Dermatology Business with $1 Billion Renaissance Acquisition: A Smart Move?
Bidness, ETC
Mylan Labs
dermatology
M&A
generics
Renaissance Acquisition Holdings
Flag link:
Head of Valeant's embattled dermatology unit exits in management shakeup
Head of Valeant's embattled dermatology unit exits in management shakeup
Fierce Pharma
Valeant Pharmaceuticals
dermatology
Flag link:
Valeant, Glaxo, Novartis Skin Drug Prices Have Soared
Valeant, Glaxo, Novartis Skin Drug Prices Have Soared
Investors.com
drug pricing
Valeant Pharmaceuticals
GSK
Novartis
dermatology
Flag link:
Valeant Creating New Program to Get Patients Dermatology Drugs
Valeant Creating New Program to Get Patients Dermatology Drugs
Bloomberg
Valeant Pharmaceuticals
dermatology
Flag link:
AbbVie Demonstrates Leadership in Dermatology with 26 Abstracts at the European Academy of Dermatology and Venereology Congress
AbbVie Demonstrates Leadership in Dermatology with 26 Abstracts at the European Academy of Dermatology and Venereology Congress
Yahoo
AbbVie
dermatology
Flag link:
Cosmo to Seek More Than $107 Million in Dermatology Unit IPO
Cosmo to Seek More Than $107 Million in Dermatology Unit IPO
Bloomberg
Cosmo Pharma
dermatology
IPOs
Flag link:

Pages